Skip to content
Agree.net – Lifestyle
Author:
Keenova Therapeutics
Keenova Therapeutics to Report Second Quarter 2026 Financial Results on August 11, 2026
July 30, 2026
Keenova Announces Publication of New Acthar® Gel (repository corticotropin injection) Manuscript in the Journal of Comparative Effectiveness Research
July 13, 2026
Keenova Announces Positive Phase 3 Results in Clinical Trial of XIAFLEX® (collagenase clostridium histolyticum) for Treating Plantar Fibromatosis
July 8, 2026
Keenova Champions Men’s Health Month with Education and Outreach
June 1, 2026